- Country: Spain
- Summary: Supply of Cabazitaxel (Doe), Riluzole (Doe), Human Hepatitis B Immunoglobulin (Doe), Mupirocin Ointment (Doe), Inhaled Budesonide (Doe) and Norepinephrine (Doe)
- EST Ref No: 128235170
- Deadline: 12 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 4312257.6
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Cabazitaxel (Doe), Riluzole (Doe), Human Hepatitis B Immunoglobulin (Doe), Mupirocin Ointment (Doe), Inhaled Budesonide (Doe) and Norepinephrine (Doe) - Spain Tender
The OSAKIDETZA - BASQUE HEALTH SERVICE - CENTRAL ORGANIZATION, a Government sector organization in Spain, has announced a new tender for Supply of Cabazitaxel (Doe), Riluzole (Doe), Human Hepatitis B Immunoglobulin (Doe), Mupirocin Ointment (Doe), Inhaled Budesonide (Doe) and Norepinephrine (Doe). This tender is published on SpainTenders under EST Ref No: 128235170 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-12.
The estimated tender value is EUR 4312257.6, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
